Physician profile
Brook Johnson
NPI 1154354223
$1,621.09
in general payments reported to CMS, 2019-2025
13 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.55 · 2023: $503 · 2024: $780 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $765.50 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $330.30 | 2023-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $88.49 | 2025 | Jornay Pm |
| Seqirus USA INC | $87.55 | 2024-2025 | Flucelvax |
| Ars Pharmaceuticals Operations, INC. | $67.33 | 2025 | Neffy |
| Pfizer INC. | $59.07 | 2023-2024 | |
| Sanofi Pasteur INC. | $56.89 | 2023-2024 | |
| Tris Pharma INC | $52.01 | 2023-2025 | Dyanavel Xr |
| Ortho-Clinical Diagnostics, INC. | $31.57 | 2024 | Sofia |
| Merck Sharp & Dohme LLC | $30.92 | 2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Astrazeneca Pharmaceuticals Lp | $21.36 | 2023 | Flumist Quadrivalent |
| Abbvie INC. | $15.55 | 2022 | |
| Abbott Laboratories | $14.55 | 2024 | Dragonfly Opstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brook Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.